Here, we describe a rare case of small cell lung cancer (SCLC) with SMARCA4 loss, characterized by an aggressive phenotype, and further discuss the molecular, pathological, and clinical features of SMARCA2 and SMARCA4 deficiency in lung cancer. Here, SMARCA2 is linked to small cell lung carcinoma.